Adherence to oral anti-diabetic drugs among patients attending a Ghanaian teaching hospital

Pharmacy Practice

Volumn 13, Issue 1, 2015, Pages

  Bruce, Suliasnaia P ^a   Acheampong, Franklin ^a   Kretchy, Irene ^b  

^a KORLE BU TEACHING HOSPITAL   (Ghana)

^b UNIVERSITY OF GHANA   (Ghana)

Author keywords

Diabetes mellitus; Ghana; Logistic models; Medication adherence; Risk factors; Type 2

Indexed keywords

GLIBENCLAMIDE; METFORMIN; ORAL ANTIDIABETIC AGENT; PIOGLITAZONE; ROSIGLITAZONE; TOLBUTAMIDE;

ADULT; AGED; ARTICLE; ASSESSMENT OF HUMANS; CROSS-SECTIONAL STUDY; DESCRIPTIVE RESEARCH; DIABETES MELLITUS; EDUCATIONAL STATUS; FEMALE; GHANA; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDICATION COMPLIANCE; MIDDLE AGED; MORISKY MEDICATION ADHERENCE SCALE; SELF CARE;

EID: 84926391616     PISSN: None     EISSN: 18863655     Source Type: Journal    
DOI: 10.18549/PharmPract.2015.01.533     Document Type: Article

References (22)

1. Wild S, Roglic G, Green A, Sicree R, King H. Global prevalence of diabetes: Estimates for the year 2000 and projections for 2030. Diabetes Care. 2004;27(5):1047-1053.
2. American Diabetes Association. Economic costs of diabetes in the U.S in 2007. Diabetes Care. 2008;31(3):596-615. doi: 10.2337/dc08-9017
3. Haynes RB, Taylor DW, Sackett DL. Compliance in Health care. Baltimore: The Johns Hopkins University Press; 1979.
4. Sabaté E. Adherence to Long-Term Therapies: Evidence for Action. Geneva: World Health Organization; 2003.
5. Bardel A, Wallander MA, Svärdsudd K. Factors associated with adherence to drug therapy: a population-based study. Eur J Clin Pharmacol. 2007;63(3):307-314.
6. Delamater AM. Improving patient adherence. Clin Diabetes. 2006;24(2):71-77. doi: 10.2337/diaclin.24.2.71
7. Amoah A. Comprehensive care in a low-income country: The Ghana Experience. Diabetes Voice. 2002;47(2):20-22.
8. Kalyango JN, Owino E, Nambuya AP. Non-adherence to diabetes treatment at Mulago Hospital in Uganda: prevalence and associated factors. Afr Health Sci. 2008;8(2):67-73.
9. Morisky DE, Green LW, Levine DM. Concurrent and predictive validity of a self-reported measure of medication adherence. Med Care. 1986;24(1):67-74.
10. Shams ME, Barakat EA. Measuring the rate of therapeutic adherence among outpatient with T2DM in Egypt. Saudi Pharm J. 2010;18(4):225-232. doi: 10.1016/j.jsps.2010.07.004
11. Hernández-Ronquillo L, Téllez-Zenteno JF, Garduño-Espinosa J, González-Acevez E. Factors associated with therapy noncompliance in type-2 diabetes patients. Salud Publica Mex. 2003;45(3):191-197.
12. Adisa R, Fakeye TO, Fasanmade A. Medication adherence among ambulatory patients with type 2 diabetes in a tertiary healthcare setting in Southwestern Nigeria. Pharm Pract (Granada). 2011;9(2):72-81.
13. Gimenes HT, Zanetti ML, Haas VJ. Factors Related to patient adherence to antidiabetic drug therapy. Rev Lat Am Enfermagem. 2009;17(1):46-51.
14. Kalyango JN, Owino E, Nambaya P. Non-adherence to diabetes treatment at Mulago Hospital in Uganda: prevalence and associated factors. Afr Health Sci. 2008;8(2):67-73.
15. Chua SS, Chua SP. Medication adherence and achievement of glycaemic targets in ambulatory type 2 diabetic patients. J Appl Pharm Sci. 2011;1(4):55-59.
16. Dailey G, Kim MS, Lian JF. Patient compliance and persistence with antihyperglycaemic drug regimens: evaluation of Medicaid patient population with type 2 diabetes mellitus. Clin Ther. 2001;23(8):1311-1320.
17. Dailey G, Kim MS, Lian JF. Patient compliance and persistence with antihyperglycaemic therapy: evaluation of a population of type 2 diabetic patients. J Int Med Res. 2002;30(1):71-79.
18. Melikian C, White TJ, Vanderplas A, Dezii CM, Chang E. Adherence to oral antidiabetic therapy in a managed care organization: a comparison of monotherapy, and fixed-dose combination therapy. Clin Ther. 2002;24(3):460-467.
19. Geok H, Anwar M, Wong PS. A Study on Compliance among Oral Hypoglycaemic Agents (OHA) Users at a public Hospital In Malaysia. 8th Asian Conference on Clinical Pharmacy. Surabaya, 2008.
20. Garay-Sevilla ME, Nava LE, Malacara JM, Huerta R, Díaz de León J, Mena A, Fajardo ME. Adherence to treatment and social support in patients with non-insulin diabetes mellitus. J Diabetes Complications. 1995;9(2):81-86.
21. Mansoor LE, Dowse R. Medicines information and adherence in HIV/AIDS patients. J Clin Pharm Ther. 2006;31(1):7-15.
22. Smith DH, Kramer JM, Perrin N, Platt R, Roblin DW, Lane K, Goodman M, Nelson WW, Yang X, Soumerai SB. A randomized trial of direct-to-patient communication to enhance adherence to beta-blocker therapy following myocardial infarction. Arch Intern Med. 2008;168(5):477-483. doi: 10.1001/archinternmed.2007.132